Establishment of an internationally recognized platform for the communication of pharmaceutical researches supported by the National New Drug Innovation Programs

doi:10.5246/jcps.2012.05.064

Abstract

Abstract:

The initiation of the National New Drug Innovation Key Technology Program marked a strategic shift of new drug discovery in China, which will greatly enhance the new drug discovery research activities. It presents a valuable opportunity for the growth and quality advancement of pharmaceutical science journals. As the only comprehensive English journal of the Chinese Pharmaceutical Association, In the new situation, Journal of Chinese Pharmaceutical Sciences (JCPS) plays a critical role in the communication of new discoveries in pharmaceutical researches to the scientific community. To fulfill the roles as an internationally recognized platform for the communication of the new drug discoveries supported by the National New Drug Innovation Programs, the JCPS editorial office will take advantage of its English language specialty, emphasize quality and digital access, and promote the advancement of the journal.

Key words: New drug innovation, Development of sci-tech periodical, Quality, Digital access, English specialty

CLC Number:

G237.5

Supporting:

Heqing Huang^*, Jian Han, Jingjing Zhang. Establishment of an internationally recognized platform for the communication of pharmaceutical researches supported by the National New Drug Innovation Programs[J]. , DOI: 10.5246/jcps.2012.05.064.

References

References

[1] Yi, Y. Multinational pharmaceutical companies set up new drugs R & D center in China [EB/OL]. [2007-07-25]. http://www.biotech.org.cn/news/news/show.php?id=53884
[2] Zhang, Y.H. From the editor's perspective: internationalization vision of editors of the academic periodicals and the new trend of the international publishing. special training “going out” of chinese academic periodical in 2012. 2012-3-23.
[3] Li, L.N. J. Chin. Pharm. Sci. 1997, 6, 57-64.
[4] Su, W.G. J. Chin. Pharm. Sci. 2009, 18, 5-6.
[5] Chen, H.B. J. Chin. Pharm. Sci. 2010, 19, 87-94.
[6] Zhai S.D. J. Chin. Pharm. Sci. 2010, 19, 125-129.
[7] Dai, Y.L. World of Science. 2011, 22, 3-4.
[8] Ren, Y.G.; Liu, R.G.; Gao, S. Acta Editologica. 2010, 22, 195-197.
[9] Qiu, D.L. The thinking of innovation development of Chinese English academic journal [EB/OL]. [2012-04-11]. http://bbs.sciencenet.cn/home.php?mod=space&uid= 314423&do=blog&id=558187
[10] Wu, Y.S. Chin. J. Nat. 2005, 27, 54.
[11] Guo, S.L.; You, S.N. Chin. J. Sci. Tech. Periodic. 2010, 21, 343-346.

参考文献

[1] 亦云. 跨国药企争相设立中国研发中心[EB/OL]. [2007-07-25].

http://www.biotech.org.cn/news/news/show.php?id=53884

[2] 张月红. 从编辑的视角谈: 学术期刊编辑的国际化视野与国际出版的最新动向. 2012年中国学术期刊 “走出去” 专题培训. 2012-3-23
[3] Li, L.N. Water soluble active components of Salvia miltior rhiza and related plants [J]. Journal of Chinese Pharmaceutical Sciences. 1997, 6, 57-64.
[4] Su, W.G. Where is the biotech industry in China headed to? [J]. J. Chin. Pharm. Sci. 2009, 18, 5-6.
[5] Chen, H. B. Development of Hong Kong Chinese Materia Medica (HKCMM) standards [J]. Journal of Chinese Pharmaceutical Sciences. 2010, 19, 87-94.
[6] Zhai, S.D. Influence of different intravenous injection containers on residual liquid volume and its economic impact [J]. Journal of Chinese Pharmaceutical Sciences. 2010, 19, 125-129.
[7] 游苏宁. 仰望星空必须脚踏实地[J]. 编辑学报. 2012, 24, 2.
[8] 代艳玲. 影响科技期刊发展的因素分析[J]. 科技世界. 2011, 22, 3-4.
[9] 任延刚, 刘盛博, 高森, 等. 科技期刊多元化发展的研究热点问题分析[J]. 编辑学报. 2010, 22, 195-197.
[10] 邱敦莲. 对我国英文学术期刊创新发展的思考[EB/OL]. [2012-04-11].
http://bbs.sciencenet.cn/home.php?mod=space&uid=314423&do=blog&id=558187

[11] 武夷山. 打破文理藩篱的意义与路径[J]. 自然杂志. 2005, 27, 54.
[12] 郭利劭, 游苏宁. 践行科学发展观提高期刊竞争力——《中华医学杂志英文版》办刊实践[J]. 中国科技期刊研究. 2010, 21, 343-346.

[1]	Shi Jin, Chengyin Li, Xinyue Jing, Yunru Peng, Shaohua Dong, Wanjin Sun. Study on quality control of Xiaozhong Ointment NO. 1 based on the relationship between quality fractions of main components in monarch and minister drugs and the clinical efficacy [J]. Journal of Chinese Pharmaceutical Sciences, 2023, 32(9): 764-771.
[2]	Yizi Zhu, Huajun Li, Yubo Zhang, Chaoran Zhao, Shuai Lu, Mingxuan Fan, Mei Han. Comparison of quality control standards of PET radiopharmaceuticals for tumor in Pharmacopoeia of Europe, the United States and People’s Republic of China [J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(3): 246-252.
[3]	Weijuan Jia, Shizhong Chen, Jianhua Sun, Zongli Bai, Yazhuo Huang, Yuankuan Zhang, Hong Wang. Quality evaluation of Polyporus umbellatus based on HPLC specific chromatogram and fingerprint analysis [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(12): 896-907.
[4]	Jinhui Shi, Ruiyue Li, Siyu Yang, Hongmei Zhang. Phytochemistry, biological properties and quality control of Chuanxiong Rhizoma: a review [J]. Journal of Chinese Pharmaceutical Sciences, 2020, 29(11): 755-779.
[5]	Xinyu Shen, Xingchen Wang, Caihong Gu, Feng Yan, Bo Pan, Lizeng Gao, Bingchun Yan, Qi Liu, Rong Hu. A novel preparation of Panax japonicas with high bioequivalence of ginsenoside Rg3 [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(9): 650-664.
[6]	Yiyi Zhao, Ruyi Guo, Haili Yin, Xintong Fu, Yougen Chen, Hongzhu Guo. Comparative study on main compounds in Ginkgo biloba L. base on mathematical statistics [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(12): 843-854.
[7]	Haoyan Jiao, Shengmei Xu, Chunlin Fan, Qingwen Zhang, Ying Wang. Chromatographic fingerprint analysis and quantitative evaluate the rhizomes of Alpinia officinarum Hance (lesser galangal) [J]. Journal of Chinese Pharmaceutical Sciences, 2019, 28(10): 728-738.
[8]	Yiyi Zhao, Hongzhu Guo, Yougen Chen, Xintong Fu. Holistic quality evaluation of Panax notoginseng extract and injection using an UPLC-QTOF-MSE based metabolomics approach [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(5): 335-345.
[9]	Rui Li, Defeng Xu, Xingqun Yang, Shouxiu Ma, Xiaoai Ge, Shuwen Zhou. Preparation and stability studies of dimethyl curcumin niosomes [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(4): 265-270.
[10]	Ling Wang, Mingbo Zhao, Yong Jiang, Pengfei Tu, Xiaoyu Guo. Quality standard study on Dictamni Cortex [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(4): 298-303.
[11]	Liqun Wang, Xiaohui Xie, Ruirui Zhou. Assessment of the quality of randomized controlled trials on pharmaceutical care for asthmatic patients in journals of mainland China [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(3): 212-221.
[12]	Rengeng Shu, Xiluan Yan, Shasha Li, Pengfei Tu. Simultaneous determination of l-calycanthine, quercetin, and kaempferol in Chimonanthi Nitentis Folium by RP-HPLC [J]. Journal of Chinese Pharmaceutical Sciences, 2017, 26(11): 805-810.
[13]	Aihua Wang, Yue Kong, Mingying Shang, Rongyun You, Guangxue Liu, Feng Xu, Shaoqing Cai. Simultaneous quantification of eight active compounds in Sinopodophyllum hexandrum by HPLC-DAD [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(6): 376-382.
[14]	Li Pan, Xi Wen, Yu Sha, Wenting Zhu, Maosheng Cheng. Synthesis of impurity B of Flumazenil [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(2): 133-136.
[15]	Qing Yang, Jing Wang, Yongze Zhang, Jing Chen, Mingli Shao. Origin, development and current status of pharmaceutical education steering organizations in China [J]. Journal of Chinese Pharmaceutical Sciences, 2015, 24(12): 816-820.